R&D Trends

ACTO deems Russian 2011 clinical trials market “adequate”

Wednesday, February 1, 2012 12:02 PM

After gathering and analyzing data, the Association of Clinical Trials Organizations (ACTO) has concluded that the 2010 crisis brought on by Russia’s new regulations and the transfer of approval authority from Roszdravnadzor to the Health Ministry has been resolved.

More... »

Survey aims to capture public attitudes on sharing genomic results

Tuesday, January 31, 2012 02:28 PM

An ethics team from the Wellcome Trust Sanger Institutein Cambridge, U.K., is launching an online survey to capture the views of as many people as possible about how they would like their genetic data handled.

More... »

Transparency Life Sciences launches as first drug developer based on open innovation

Tuesday, January 31, 2012 02:15 PM

Transparency Life Sciences (TLS), the first drug development company based on open innovation, has officially launched, with the introduction of a prototype of its crowdsourced web platform that allows patients, physicians, researchers and other stakeholders to contribute to the design of clinical studies. 

More... »

International collaboration to combat 10 neglected tropical diseases by 2020

Monday, January 30, 2012 03:49 PM

Thirteen pharmaceutical companies, the U.S., U.K. and U.A.E governments, the Bill & Melinda Gates Foundation, the World Bank and other global health organizations will join forces to eliminate or control 10 neglected tropical diseases (NTDs) by the end of the decade.

More... »

HUYA forms strategic partnership with Tianjin Institute

Monday, January 30, 2012 02:24 PM

HUYA Bioscience International has formed a strategic partnership with the Tianjin Institute of Pharmaceutical Research (TIPR). The collaborative agreement will promote advancement of China’s drug innovations.

More... »

Almirall and Galapagos enter into research alliance

Friday, January 27, 2012 01:57 PM

Barcelona, Spain-basedAlmirall has formed a research alliance with BioFocus, an affiliate of Galapagos. The three-year collaboration is aimed at delivering drug development candidates directed to a key respiratory target of interest to Almirall. 

More... »

Joslin Diabetes Center to build translational center for the cure of diabetes

Thursday, January 26, 2012 12:48 PM

Boston-based Joslin Diabetes Center has received a $5 million grant from the Massachusetts Life Sciences Center. The grant is among the highest amounts ever received to support diabetes research in Massachusetts.

More... »

Alzheimer's Challenge 2012 seeks new tools to improve Alzheimer's care

Thursday, January 26, 2012 10:47 AM

South San Francisco-based Janssen Alzheimer Immunotherapy, together with Pfizer—its collaborator on the Alzheimer's Immunotherapy Program (AIP)—and the Geoffrey Beene Gives Back Alzheimer's Initiative, have introduced the Alzheimer's Challenge 2012, calling for inventive concepts to help improve the diagnostic identification and tracking of Alzheimer's disease.

More... »

Novo Nordisk establishes type I diabetes R&D center in Seattle

Wednesday, January 25, 2012 09:07 AM

Denmark-based Novo Nordisk will establish a type I diabetes R&D center in Seattle, Wash.

More... »

Humane Society urges European Union to lead cutting-edge research

Tuesday, January 24, 2012 10:43 AM

Humane Society International/Europe (HSI) urged the European Union to lead the world in cutting-edge research and testing as it kicked off discussions about how to spend its Horizon 2020 research funding budget. Horizon 2020, devised to strengthen the E.U.’s position in science, is being debated by the E.U. Parliament’s Industry, Research and Energy Committee.

More... »